BrightSpring Health Services - BTSG Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $15.85
  • Forecasted Upside: 40.02%
  • Number of Analysts: 11
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 11 Buy Ratings
  • 0 Strong Buy Ratings
$11.32
▼ -0.11 (-0.96%)

This chart shows the closing price for BTSG by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New BrightSpring Health Services Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for BTSG and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for BTSG

Analyst Price Target is $15.85
▲ +40.02% Upside Potential
This price target is based on 11 analysts offering 12 month price targets for BrightSpring Health Services in the last 3 months. The average price target is $15.85, with a high forecast of $23.00 and a low forecast of $11.50. The average price target represents a 40.02% upside from the last price of $11.32.

This chart shows the closing price for BTSG for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Buy

The current consensus among 11 polled investment analysts is to buy stock in BrightSpring Health Services. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 11 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/3/2022
  • 0 strong buy ratings
  • 11 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/3/2023
  • 0 strong buy ratings
  • 11 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/1/2023
  • 0 strong buy ratings
  • 11 buy ratings
  • 0 hold ratings
  • 0 sell ratings
8/30/2023
  • 0 strong buy ratings
  • 11 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/28/2023
  • 0 strong buy ratings
  • 11 buy ratings
  • 0 hold ratings
  • 0 sell ratings
2/26/2024
  • 0 strong buy ratings
  • 11 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/26/2024
  • 0 strong buy ratings
  • 11 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/26/2024

Latest Recommendations

  • 0 strong buy ratings
  • 11 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/6/2024Wells Fargo & CompanyBoost TargetOverweight ➝ Overweight$15.00 ➝ $16.00Low
3/6/2024HSBCInitiated CoverageBuy$13.00Low
3/4/2024The Goldman Sachs GroupLower TargetBuy ➝ Buy$26.00 ➝ $23.00Low
2/27/2024Deutsche Bank AktiengesellschaftUpgradeHold ➝ Buy$11.50Low
2/20/2024Leerink PartnrsReiterated RatingOutperformLow
2/20/2024GuggenheimInitiated CoverageBuy$15.00Low
2/20/2024SVB LeerinkInitiated CoverageOutperform$15.00Low
2/20/2024Bank of AmericaInitiated CoverageBuy$14.00Low
2/20/2024UBS GroupInitiated CoverageBuy$15.00Low
2/20/2024Morgan StanleyInitiated CoverageOverweight$18.00Low
2/20/2024Wells Fargo & CompanyInitiated CoverageOverweight$15.00Low
2/20/2024The Goldman Sachs GroupInitiated CoverageBuy$26.00Low
2/20/2024Jefferies Financial GroupInitiated CoverageBuy$18.00Low
2/20/2024Deutsche Bank AktiengesellschaftInitiated CoverageHold ➝ Hold$11.50Low
(Data available from 5/27/2019 forward)

News Sentiment Rating

0.64 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/29/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
11/28/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
12/28/2023
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
1/27/2024
  • 3 very positive mentions
  • 11 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
2/26/2024
  • 12 very positive mentions
  • 17 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
3/27/2024
  • 0 very positive mentions
  • 7 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/26/2024
  • 9 very positive mentions
  • 13 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
5/26/2024

Current Sentiment

  • 9 very positive mentions
  • 13 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
BrightSpring Health Services logo
BrightSpring Health Services, Inc. operates a home and community-based healthcare services platform in the United States. The company's platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations. It serves patients through clinical providers and pharmacists. The company was formerly known as Phoenix Parent Holdings Inc. and changed its name to BrightSpring Health Services, Inc. in May 2021. BrightSpring Health Services, Inc. was founded in 1974 and is headquartered in Louisville, Kentucky.
Read More

Today's Range

Now: $11.32
Low: $11.16
High: $11.46

50 Day Range

MA: $10.65
Low: $8.83
High: $11.63

52 Week Range

Now: $11.32
Low: $7.85
High: $12.14

Volume

298,300 shs

Average Volume

1,878,057 shs

Market Capitalization

$1.94 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of BrightSpring Health Services?

The following equities research analysts have issued research reports on BrightSpring Health Services in the last year: Bank of America Co., Deutsche Bank Aktiengesellschaft, Guggenheim, HSBC Holdings plc, Jefferies Financial Group Inc., Leerink Partnrs, Morgan Stanley, SVB Leerink LLC, The Goldman Sachs Group, Inc., UBS Group AG, and Wells Fargo & Company.
View the latest analyst ratings for BTSG.

What is the current price target for BrightSpring Health Services?

10 Wall Street analysts have set twelve-month price targets for BrightSpring Health Services in the last year. Their average twelve-month price target is $15.85, suggesting a possible upside of 40.0%. The Goldman Sachs Group, Inc. has the highest price target set, predicting BTSG will reach $23.00 in the next twelve months. Deutsche Bank Aktiengesellschaft has the lowest price target set, forecasting a price of $11.50 for BrightSpring Health Services in the next year.
View the latest price targets for BTSG.

What is the current consensus analyst rating for BrightSpring Health Services?

BrightSpring Health Services currently has 11 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe BTSG will outperform the market and that investors should add to their positions of BrightSpring Health Services.
View the latest ratings for BTSG.

What other companies compete with BrightSpring Health Services?

How do I contact BrightSpring Health Services' investor relations team?

BrightSpring Health Services' physical mailing address is 805 North Whittington Parkway, Louisville, KY 40222, United States. The company's listed phone number is 502-394-2100 and its investor relations email address is [email protected]. The official website for BrightSpring Health Services is www.brightspringhealth.com. Learn More about contacing BrightSpring Health Services investor relations.